About Reach Separations
Reach Separations is a company based in Nottingham (United Kingdom) founded in 2011 was acquired by CatSci in June 2024.. The company has 16 employees as of January 31, 2022. Reach Separations offers products and services including Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification. Reach Separations operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and PharmaFluidics, among others.
- Headquarter Nottingham, United Kingdom
- Employees 16 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reach Separations Limited
- Date of Incorporation 15 Nov, 2011
- Jurisdiction NOTTINGHAM
-
Annual Revenue
-
Net Profit
$343.94 K (USD)-52as on Jan 31, 2023
-
EBITDA
-
Latest Funding Round
-
Investors
Royal Society of Chemistry
& 1 more
-
Employee Count
16
as on Jan 31, 2022
-
Acquired by
CatSci
(Jun 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reach Separations
Reach Separations offers a comprehensive portfolio of products and services, including Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides rapid analysis and purification for various samples
Offers purification services for targeted molecular compounds
Purifies substances for pharmaceutical applications
Handles purification of peptides for research and industry
Funding Insights of Reach Separations
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Grant - Reach Separations | Valuation |
investors |
|
| Dec, 2014 | Amount | Grant - Reach Separations | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Reach Separations
Reach Separations has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Royal Society of Chemistry and CatSci. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A community focused on science & technology
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to pharmaceutical clients worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Reach Separations
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Reach Separations
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reach Separations Comparisons
Competitors of Reach Separations
Reach Separations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and PharmaFluidics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary filtration solutions for life science
|
|
| domain | founded_year | HQ Location |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Reach Separations
Frequently Asked Questions about Reach Separations
When was Reach Separations founded?
Reach Separations was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Reach Separations located?
Reach Separations is headquartered in Nottingham, United Kingdom.
How many employees does Reach Separations have?
As of Jan 31, 2022, the latest employee count at Reach Separations is 16.
What does Reach Separations do?
Reach Separations uses HPLC (High-Performance Liquid Chromatography) and SFC (Supercritical Fluid Chromatography) technologies to offer small molecule analysis and purification services to the pharmaceutical, agrochemical and fine chemical sectors. The company claims to have the expertise for both chiral and achiral purification and separation. They can use both HPLC and SFC in parallel. Reach Separations claims to use a wide selection of columns from a variety of different Chiral Stationary Phase (CSP) manufacturers in its chiral screens as compared to other screening methodologies which only employ one brand of the column. They have 5 preparatives HPLC and 5 preparative SFCs for chiral and 3 preparatives HPLC and SFC capabilities for achiral separations. The company also has capabilities such as UHPLC-MS system with diode array detection (DAD) for providing high-quality final purity data.
Who are the top competitors of Reach Separations?
Reach Separations's top competitors include ChromaTan, Sepragen and Sepax Technologies.
What products or services does Reach Separations offer?
Reach Separations offers Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification.
Who are Reach Separations's investors?
Reach Separations has 2 investors. Key investors include Royal Society of Chemistry, and CatSci.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.